(2008). Comparison of two doses of intravitreal bevacizumab (avastin) for treatment of macular edema secondary to branch retinal vein occlusion: Results from the Pan-American collaborative retina study group at 6 months of follow-up.
Chicago Style (17th ed.) CitationComparison of Two Doses of Intravitreal Bevacizumab (avastin) for Treatment of Macular Edema Secondary to Branch Retinal Vein Occlusion: Results from the Pan-American Collaborative Retina Study Group at 6 Months of Follow-up. 2008.
MLA (8th ed.) CitationComparison of Two Doses of Intravitreal Bevacizumab (avastin) for Treatment of Macular Edema Secondary to Branch Retinal Vein Occlusion: Results from the Pan-American Collaborative Retina Study Group at 6 Months of Follow-up. 2008.
Warning: These citations may not always be 100% accurate.